trial

Morphological, Structural and Functional Neural Substrates of Quality of Life in Schizophrenia

NCTId NCT01295411
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 100 (estimated)
Sponsored by Assistance Publique Hopitaux De Marseille
Primary completion 2015-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
100 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2011-01
Primary completion
2015-01
Eligibility
ALL · 18 Years · 40 Years

Interventions & indications

Drugs
Magnetic Resonance ImagingEVALUATION NEUROPSYCHOLOGICAL

Sponsors

Assistance Publique Hopitaux De MarseilleLead Sponsor

Investigators

1
BERNARD BELAIGUESStudy Director

Sites

1 total
Marseille, France

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2015-01
Status
UNKNOWN
relationships
The graph out of here
drug
Magnetic Resonance Imaging
drug
EVALUATION NEUROPSYCHOLOGICAL
drug
lead_sponsor
Assistance Publique Hopitaux De Marseille
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
BERNARD BELAIGUES
person